Regulatory and HTA framework for herbal medicines in Indonesia
This review provides the first integrated synthesis of evidence generation, regulatory pathways, HTA processes, PV systems, and financing-governance alignment for herbal medicines in Indonesia. Findings highlight the need to strengthen evidence standards, adapt HTA methodologies, reinforce PV and laboratory capacity, and improve regulatory-financing linkages. Implementing the proposed framework can enhance policy coherence, regulatory transparency, and safety oversight, supporting more credible and evidence-informed integration of herbal medicines into Indonesia's health system.
Authors
- Arry Yanuar
- Taruna Ikrar (ORCID: https://orcid.org/0000-0002-8081-8528)
- Rani Sauriasari
- Mohamad Kashuri
- Vishnu Juwono
Institutions
- University of Indonesia (ID)
- Food and Drug Administration (TH)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1080/20523211.2026.2640252
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 0.00